Association between the CTLA-4 +49A/G polymorphism and type 1 diabetes: A meta-analysis

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 11, 2012, Pages 1336-1342

  Si, Xiaoyu ^a   Zhang, Xiufeng ^a   Luo, Ying ^a   Tang, Wenru ^a  

^a KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; DNA POLYMORPHISM; ETHNICITY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDLINE; META ANALYSIS; PUBLISHING; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CTLA-4 ANTIGEN; DIABETES MELLITUS, TYPE 1; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; POLYMORPHISM, GENETIC;

EID: 84868007779     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0169     Document Type: Article

References (53)

1. Abe T, Takino H, Yamasaki H, et al. (1999) CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes. Diabetes Res Clin Pract 46:169-175. (Pubitemid 29509926)
2. Ahmedov G, Ahmedova L, Sedlakova P, Cinek O (2006) Genetic association of type 1 diabetes in an Azerbaijanian population: the HLA-DQ,-DRB1*04, the insulin gene, and CTLA4. Pediatr Diabetes 7:88-93.
3. Awata T, Kurihara S, Iitaka M, et al. (1998) Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 47:128-129. (Pubitemid 28030819)
4. Balic I, Angel B, Codner E, et al. (2009) Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children. Hum Immunol 70:116-120.
5. Baniasadi V, Narain N, Goswami R, Das SN (2006) Promoter region-318 C/T and-1661A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians. Tissue Antigens 67:383-389.
6. Benmansour J, Stayoussef M, Al-Jenaidi FA, et al. (2010) Association of single nucleotide polymorphisms in cytotoxic Tlymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians. Clin Vaccine Immunol 17:1473-1477.
7. Bouqbis L, Izaabel H, Akhayat O, et al. (2003) Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population. Genes Immun 4:132-137. (Pubitemid 38967587)
8. Caputo M, Cerrone GE, Lopez AP, et al. (2005) Cytotoxic T lymphocyte antigen 4 heterozygous codon 49A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA). Autoimmunity 38:277-281. (Pubitemid 40974957)
9. Cinek O, Drevinek P, Sumnik Z, et al. (2002) The CTLA4 + 49A/G dimorphism is not associated with type 1 diabetes in Czech children. Eur J Immunogenet 29:219-222. (Pubitemid 34621795)
10. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188. (Pubitemid 17189972)
11. Djilali-Saiah I, Larger E, Harfouch-Hammoud E, et al. (1998) No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM. Diabetes 47:125-127. (Pubitemid 28030818)
12. Donner H, Rau H, Walfish PG, et al. (1997) CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82:143-146. (Pubitemid 27021285)
13. Douroudis K, Laine AP, Heinonen M, et al. (2009) Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates. Hum Immunol 70:536-539.
14. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634. (Pubitemid 27387172)
15. Ei Wafai RJ, Chmaisse HN, Makki RF, Fakhoury H (2011) Association of HLA class II alleles and CTLA-4 polymorphism with type 1 diabetes. Saudi J Kidney Dis Transpl 22:273-281.
16. Fajardy I, Vambergue A, Stuckens C, et al. (2002) CTLA-4 49A/G dimorphism and type 1 diabetes susceptibility: a French case-control study and segregation analysis. Evidence of a maternal effect. Eur J Immunogenet 29:251-257. (Pubitemid 34621800)
17. Ferreira AC, Gomes KB, Sampaio IB, et al. (2009) Type 1 diabetes susceptibility determined by HLA alleles and CTLA-4 and insulin genes polymorphisms in Brazilians. Arq Bras Endocrinol Metabol 53:368-373.
18. Haller K, Kisand K, Nemvalts V, et al. (2004) Type 1 diabetes is insulin-2221 MspI and CTLA-4 + 49A/G polymorphism dependent. Eur J Clin Invest 34:543-548. (Pubitemid 39120223)
19. Haller K, Kisand K, Pisarev H, et al. (2007) Insulin gene VNTR, CTLA-4 + 49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group. Tissue Antigens 69:121-127. (Pubitemid 46174865)
20. Hauache OM, Reis AF, Oliveira CS, et al. (2005) Estimation of diabetes risk in Brazilian population by typing for polymorphisms in HLA-DR-DQ, INS and CTLA-4 genes. Disease markers 21:139-145. (Pubitemid 41566732)
21. Hayashi H, Kusaka I, Nagasaka S, et al. (1999) Association of CTLA-4 polymorphism with positive anti-GAD antibody in Japanese subjects with type 1 diabetes mellitus. Clin Endocrinol 51:793-799. (Pubitemid 30050831)
22. Ide A, Kawasaki E, Abiru N, et al. (2004) Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun 22:73-78. (Pubitemid 38050215)
23. Jin P, Xiang B, Lin J, et al. (2009) Association of CTLA-4 + 49A/G and CT60 gene polymorphism with type 1 diabetes and thyroid autoimmunity. Zhonghua yi xue za zhi 89:1246-1249.
24. Jung MH, Yu J, Shin CH, et al. (2009) Association of cytotoxic T lymphocyte antigen-4 gene polymorphisms and HLA class II alleles with the development of type 1 diabetes in Korean children and adolescents. J Korean Med Sci 24:1004-1009.
25. Karvonen M (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabetic Med 23:857-866. (Pubitemid 44141074)
26. Kavvoura FK, Ioannidis JP (2005) CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol 162:3-16. (Pubitemid 40884995)
27. Kawasaki E, Imagawa A, Makino H, et al. (2008) Differences in the contribution of the CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients. Diabetes Care 31:1608-1610.
28. Kikuoka N, Sugihara S, Yanagawa T, et al. (2001) Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies. Clin Endocrinol 55:597-603. (Pubitemid 34204442)
29. Klitz W, Bugawan TL, Panelo A, et al. (2002) Association of CTLA-4 variation with type I diabetes in Filipinos. Immunogenetics 54:310-313. (Pubitemid 34983948)
30. Korolija M, Renar IP, Hadzija M, et al. (2009) Association of PTPN22 C1858T and CTLA-4 A49G polymorphisms with type 1 diabetes in Croatians. Diabetes Res Clin Pract 86:e54-e57.
31. Krokowski M, Bodalski J, Bratek A, et al. (1998) CTLA-4 gene polymorphism is associated with predisposition to IDDM in a population from central Poland. Diabetes Metab 24:241-243. (Pubitemid 28290090)
32. Lee YJ, Huang FY, Lo FS, et al. (2000) Association of CTLA4 gene A-G polymorphism with type 1 diabetes in Chinese children. Clin Endocrinol 52:153-157.
33. Lemos MC, Coutinho E, Gomes L, et al. (2009) The CTLA4 + 49A/G polymorphism is not associated with susceptibility to type 1 diabetes mellitus in the Portuguese population. Int J Immunogenet 36:193-195.
34. Li XH, Li TL, Yang Z, et al. (2000) A nine-year prospective study on the incidence of childhood type 1 diabetes mellitus in China. Biomed Environ Sci 13:263-270.
35. Ma Y, Tang X, Chang W, et al. (2002) CTLA-4 gene A/G polymorphism associated with diabetes mellitus in Han Chinese. Chinese Med J 115:1248-1250. (Pubitemid 34947353)
36. Mantel N, Haenszel W(1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
37. McCormack RM, Maxwell AP, Carson D, et al. (2001) Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population. Genes Immun 2:233-235. (Pubitemid 33676989)
38. Mochizuki M, Amemiya S, Kobayashi K, et al. (2003) Association of the CTLA-4 gene 49A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children. Diabetes Care 26:843-847. (Pubitemid 36929353)
39. Mojtahedi Z, Omrani GR, Doroudchi M, Ghaderi A (2005) CTLA-4 + 49A/G polymorphism is associated with predisposition to type 1 diabetes in Iranians. Diabetes Res Clin Pract 68:111-116. (Pubitemid 40602617)
40. Momin S, Flores S, Angel BB, et al. (2009) Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes. Diabetes Res Clin Pract 83:289-294.
41. Mosaad YM, Elsharkawy AA, El-Deek BS (2012) Association of CTLA-4 ( + 49A/G) gene polymorphism with type 1 diabetes mellitus in Egyptian children. Immunol Investigat 41:28-37.
42. Nistico L, Buzzetti R, Pritchard LE, et al. (1996) The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 5:1075-1080. (Pubitemid 26232296)
43. Ongagna JC, Sapin R, Pinget M, Belcourt A (2002) Markers for risk of type 1 diabetes in relatives of Alsacian patients with type 1 diabetes. Int J Exp Diabetes Res 3:1-9. (Pubitemid 35174540)
44. Osei-Hyiaman D, Hou L, Zhiyin R, et al. (2001) Association of a novel point mutation (C159G) of the CTLA4 gene with type 1 diabetes in West Africans but not in Chinese. Diabetes 50:2169-2171. (Pubitemid 33643688)
45. Patterson CC, Dahlquist GG, Gyurus E, et al. (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373:2027-2033.
46. Perez BF, Codner DE, Angel BB, et al. (2009) 49A/G genetic polymorphism of cytotoxic T lymphocyte associated antigen 4 (CTLA-4) in type 7 diabetes: association with autoantibodies and cytokines. Revista Med Chile 137:321-328.
47. Philip B, Isabel W (2011) Association of cytotoxic T lymphocyteassociated antigen 4 gene single nucleotide polymorphism with type 1 diabetes mellitus in Madurai population of Southern India. Indian J Hum Genet 17:85-89.
48. Saleh HM, Rohowsky N, Leski M (2008) The CTLA4-819 C/T and + 49A/G dimorphisms are associated with type 1 diabetes in Egyptian children. Indian J Hum Genet 14:92-98.
49. Takara M, Komiya I, Kinjo Y, et al. (2000) Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease. Diabetes Care 23:975-978. (Pubitemid 30480026)
50. Van der Auwera BJ, Vandewalle CL, Schuit FC, et al. (1997) CTLA-4 gene polymorphism confers susceptibility to insulindependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian diabetes registry. Clin Exp Immunol 110:98-103. (Pubitemid 27428521)
51. Wood JP, Pani MA, Bieda K, et al. (2002) A recently described polymorphism in the CD28 gene on chromosome 2q33 is not associated with susceptibility to type 1 diabetes. Eur J immunogenet 29:347-349. (Pubitemid 34779676)
52. Yanagawa T, Maruyama T, Gomi K, et al. (1999) Lack of association between CTLA-4 gene polymorphism and IDDM in Japanese subjects. Autoimmunity 29:53-56. (Pubitemid 29097572)
53. Zalloua PA, Abchee A, Shbaklo H, et al. (2004) Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene. Hum Immunol 65:719-724. (Pubitemid 39061169)